nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—SST—blood vessel—melanoma	0.03	0.21	CbGeAlD
Cysteamine—NPY2R—head—melanoma	0.0232	0.162	CbGeAlD
Cysteamine—SST—neck—melanoma	0.0215	0.15	CbGeAlD
Cysteamine—SST—eye—melanoma	0.016	0.112	CbGeAlD
Cysteamine—MPO—endothelium—melanoma	0.0131	0.0916	CbGeAlD
Cysteamine—MPO—blood vessel—melanoma	0.0121	0.0845	CbGeAlD
Cysteamine—Skin striae—Bleomycin—melanoma	0.0111	0.0423	CcSEcCtD
Cysteamine—SST—head—melanoma	0.00908	0.0634	CbGeAlD
Cysteamine—SST—lymph node—melanoma	0.00635	0.0444	CbGeAlD
Cysteamine—Cerebral ischaemia—Temozolomide—melanoma	0.00618	0.0235	CcSEcCtD
Cysteamine—MPO—skin of body—melanoma	0.0056	0.0391	CbGeAlD
Cysteamine—Encephalopathy—Carmustine—melanoma	0.00482	0.0183	CcSEcCtD
Cysteamine—Pain in extremity—Vemurafenib—melanoma	0.00424	0.0161	CcSEcCtD
Cysteamine—Scotoma—Carmustine—melanoma	0.00407	0.0155	CcSEcCtD
Cysteamine—Scotoma—Temozolomide—melanoma	0.00393	0.0149	CcSEcCtD
Cysteamine—MPO—head—melanoma	0.00366	0.0255	CbGeAlD
Cysteamine—Thinking abnormal—Carmustine—melanoma	0.00338	0.0128	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Temozolomide—melanoma	0.00299	0.0113	CcSEcCtD
Cysteamine—Redness—Docetaxel—melanoma	0.00294	0.0112	CcSEcCtD
Cysteamine—Connective tissue disorder—Vemurafenib—melanoma	0.00288	0.011	CcSEcCtD
Cysteamine—Mental disability—Carmustine—melanoma	0.00268	0.0102	CcSEcCtD
Cysteamine—Scotoma—Docetaxel—melanoma	0.00262	0.00993	CcSEcCtD
Cysteamine—Mental disability—Temozolomide—melanoma	0.00259	0.00984	CcSEcCtD
Cysteamine—MPO—lymph node—melanoma	0.00256	0.0179	CbGeAlD
Cysteamine—Erythema—Vemurafenib—melanoma	0.00256	0.0097	CcSEcCtD
Cysteamine—Malnutrition—Vemurafenib—melanoma	0.00256	0.0097	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.00249	0.00947	CcSEcCtD
Cysteamine—Eye pain—Carmustine—melanoma	0.00249	0.00944	CcSEcCtD
Cysteamine—Lethargy—Dactinomycin—melanoma	0.00245	0.00929	CcSEcCtD
Cysteamine—Gastroenteritis—Temozolomide—melanoma	0.00245	0.00929	CcSEcCtD
Cysteamine—Eye pain—Temozolomide—melanoma	0.0024	0.00912	CcSEcCtD
Cysteamine—Liver function test abnormal—Dactinomycin—melanoma	0.00221	0.0084	CcSEcCtD
Cysteamine—Bone disorder—Docetaxel—melanoma	0.0022	0.00835	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00216	0.0082	CcSEcCtD
Cysteamine—Affect lability—Temozolomide—melanoma	0.00213	0.0081	CcSEcCtD
Cysteamine—Ataxia—Carmustine—melanoma	0.00211	0.00801	CcSEcCtD
Cysteamine—Anaphylactic shock—Vemurafenib—melanoma	0.00209	0.00792	CcSEcCtD
Cysteamine—Liver function test abnormal—Carmustine—melanoma	0.00207	0.00787	CcSEcCtD
Cysteamine—Mood swings—Temozolomide—melanoma	0.00205	0.0078	CcSEcCtD
Cysteamine—Nervous system disorder—Vemurafenib—melanoma	0.00205	0.00777	CcSEcCtD
Cysteamine—Ataxia—Temozolomide—melanoma	0.00204	0.00774	CcSEcCtD
Cysteamine—Skin disorder—Vemurafenib—melanoma	0.00203	0.00769	CcSEcCtD
Cysteamine—Dehydration—Temozolomide—melanoma	0.00202	0.00766	CcSEcCtD
Cysteamine—Phosphatase alkaline increased—Docetaxel—melanoma	0.00199	0.00754	CcSEcCtD
Cysteamine—Decreased appetite—Vemurafenib—melanoma	0.00181	0.00688	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Vemurafenib—melanoma	0.0018	0.00684	CcSEcCtD
Cysteamine—Fatigue—Vemurafenib—melanoma	0.0018	0.00683	CcSEcCtD
Cysteamine—Constipation—Vemurafenib—melanoma	0.00178	0.00677	CcSEcCtD
Cysteamine—Renal failure—Carmustine—melanoma	0.0017	0.00645	CcSEcCtD
Cysteamine—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00166	0.0063	CcSEcCtD
Cysteamine—Body temperature increased—Vemurafenib—melanoma	0.00165	0.00626	CcSEcCtD
Cysteamine—Erythema—Bleomycin—melanoma	0.00155	0.00588	CcSEcCtD
Cysteamine—Hallucination—Carmustine—melanoma	0.00154	0.00586	CcSEcCtD
Cysteamine—Hypersensitivity—Vemurafenib—melanoma	0.00154	0.00583	CcSEcCtD
Cysteamine—Connective tissue disorder—Carmustine—melanoma	0.00153	0.00579	CcSEcCtD
Cysteamine—Asthenia—Vemurafenib—melanoma	0.0015	0.00568	CcSEcCtD
Cysteamine—Hallucination—Temozolomide—melanoma	0.00149	0.00567	CcSEcCtD
Cysteamine—Urinary tract disorder—Temozolomide—melanoma	0.00148	0.00563	CcSEcCtD
Cysteamine—Connective tissue disorder—Temozolomide—melanoma	0.00147	0.0056	CcSEcCtD
Cysteamine—Lethargy—Docetaxel—melanoma	0.00147	0.00559	CcSEcCtD
Cysteamine—Urethral disorder—Temozolomide—melanoma	0.00147	0.00558	CcSEcCtD
Cysteamine—Erythema—Dactinomycin—melanoma	0.00144	0.00548	CcSEcCtD
Cysteamine—Pain in extremity—Docetaxel—melanoma	0.00144	0.00548	CcSEcCtD
Cysteamine—Anaemia—Bleomycin—melanoma	0.00143	0.00543	CcSEcCtD
Cysteamine—Diarrhoea—Vemurafenib—melanoma	0.00143	0.00542	CcSEcCtD
Cysteamine—Leukopenia—Bleomycin—melanoma	0.00139	0.00526	CcSEcCtD
Cysteamine—Dizziness—Vemurafenib—melanoma	0.00138	0.00524	CcSEcCtD
Cysteamine—Mental disorder—Carmustine—melanoma	0.00136	0.00516	CcSEcCtD
Cysteamine—Ataxia—Docetaxel—melanoma	0.00136	0.00515	CcSEcCtD
Cysteamine—Immune system disorder—Temozolomide—melanoma	0.00136	0.00515	CcSEcCtD
Cysteamine—Erythema—Carmustine—melanoma	0.00135	0.00513	CcSEcCtD
Cysteamine—Malnutrition—Carmustine—melanoma	0.00135	0.00513	CcSEcCtD
Cysteamine—Dehydration—Docetaxel—melanoma	0.00134	0.00509	CcSEcCtD
Cysteamine—Anaemia—Dactinomycin—melanoma	0.00133	0.00507	CcSEcCtD
Cysteamine—Liver function test abnormal—Docetaxel—melanoma	0.00133	0.00506	CcSEcCtD
Cysteamine—Vomiting—Vemurafenib—melanoma	0.00133	0.00503	CcSEcCtD
Cysteamine—Rash—Vemurafenib—melanoma	0.00132	0.00499	CcSEcCtD
Cysteamine—Mental disorder—Temozolomide—melanoma	0.00131	0.00499	CcSEcCtD
Cysteamine—Dermatitis—Vemurafenib—melanoma	0.00131	0.00499	CcSEcCtD
Cysteamine—Headache—Vemurafenib—melanoma	0.00131	0.00496	CcSEcCtD
Cysteamine—Erythema—Temozolomide—melanoma	0.00131	0.00496	CcSEcCtD
Cysteamine—Malnutrition—Temozolomide—melanoma	0.00131	0.00496	CcSEcCtD
Cysteamine—Discomfort—Bleomycin—melanoma	0.0013	0.00494	CcSEcCtD
Cysteamine—Leukopenia—Dactinomycin—melanoma	0.00129	0.00491	CcSEcCtD
Cysteamine—Confusional state—Bleomycin—melanoma	0.00127	0.00484	CcSEcCtD
Cysteamine—Tremor—Carmustine—melanoma	0.00127	0.00481	CcSEcCtD
Cysteamine—Anaphylactic shock—Bleomycin—melanoma	0.00126	0.0048	CcSEcCtD
Cysteamine—Anaemia—Carmustine—melanoma	0.00125	0.00474	CcSEcCtD
Cysteamine—Agitation—Carmustine—melanoma	0.00124	0.00472	CcSEcCtD
Cysteamine—Nausea—Vemurafenib—melanoma	0.00124	0.0047	CcSEcCtD
Cysteamine—Tremor—Temozolomide—melanoma	0.00122	0.00465	CcSEcCtD
Cysteamine—Discomfort—Dactinomycin—melanoma	0.00121	0.00461	CcSEcCtD
Cysteamine—Leukopenia—Carmustine—melanoma	0.00121	0.00459	CcSEcCtD
Cysteamine—Anaemia—Temozolomide—melanoma	0.00121	0.00458	CcSEcCtD
Cysteamine—Anorexia—Bleomycin—melanoma	0.0012	0.00457	CcSEcCtD
Cysteamine—Agitation—Temozolomide—melanoma	0.0012	0.00456	CcSEcCtD
Cysteamine—Convulsion—Carmustine—melanoma	0.00117	0.00445	CcSEcCtD
Cysteamine—Leukopenia—Temozolomide—melanoma	0.00117	0.00444	CcSEcCtD
Cysteamine—Hypertension—Carmustine—melanoma	0.00117	0.00443	CcSEcCtD
Cysteamine—Convulsion—Temozolomide—melanoma	0.00113	0.0043	CcSEcCtD
Cysteamine—Hypertension—Temozolomide—melanoma	0.00113	0.00428	CcSEcCtD
Cysteamine—Anorexia—Dactinomycin—melanoma	0.00112	0.00427	CcSEcCtD
Cysteamine—Confusional state—Carmustine—melanoma	0.00111	0.00422	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0011	0.00419	CcSEcCtD
Cysteamine—Discomfort—Temozolomide—melanoma	0.0011	0.00417	CcSEcCtD
Cysteamine—Decreased appetite—Bleomycin—melanoma	0.0011	0.00417	CcSEcCtD
Cysteamine—Renal failure—Docetaxel—melanoma	0.00109	0.00415	CcSEcCtD
Cysteamine—Confusional state—Temozolomide—melanoma	0.00107	0.00408	CcSEcCtD
Cysteamine—Anaphylactic shock—Temozolomide—melanoma	0.00107	0.00405	CcSEcCtD
Cysteamine—Anorexia—Carmustine—melanoma	0.00105	0.00399	CcSEcCtD
Cysteamine—Nervous system disorder—Temozolomide—melanoma	0.00105	0.00397	CcSEcCtD
Cysteamine—Feeling abnormal—Bleomycin—melanoma	0.00104	0.00395	CcSEcCtD
Cysteamine—Skin disorder—Temozolomide—melanoma	0.00104	0.00393	CcSEcCtD
Cysteamine—Decreased appetite—Dactinomycin—melanoma	0.00102	0.00389	CcSEcCtD
Cysteamine—Fatigue—Dactinomycin—melanoma	0.00102	0.00386	CcSEcCtD
Cysteamine—Anorexia—Temozolomide—melanoma	0.00102	0.00386	CcSEcCtD
Cysteamine—Urticaria—Bleomycin—melanoma	0.001	0.00381	CcSEcCtD
Cysteamine—Body temperature increased—Bleomycin—melanoma	0.000999	0.00379	CcSEcCtD
Cysteamine—Urinary tract disorder—Docetaxel—melanoma	0.000985	0.00374	CcSEcCtD
Cysteamine—Somnolence—Carmustine—melanoma	0.000981	0.00372	CcSEcCtD
Cysteamine—Connective tissue disorder—Docetaxel—melanoma	0.00098	0.00372	CcSEcCtD
Cysteamine—Urethral disorder—Docetaxel—melanoma	0.000978	0.00371	CcSEcCtD
Cysteamine—Feeling abnormal—Dactinomycin—melanoma	0.000971	0.00369	CcSEcCtD
Cysteamine—Gastrointestinal pain—Dactinomycin—melanoma	0.000964	0.00366	CcSEcCtD
Cysteamine—Decreased appetite—Carmustine—melanoma	0.000959	0.00364	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Carmustine—melanoma	0.000952	0.00362	CcSEcCtD
Cysteamine—Somnolence—Temozolomide—melanoma	0.000948	0.0036	CcSEcCtD
Cysteamine—Constipation—Carmustine—melanoma	0.000943	0.00358	CcSEcCtD
Cysteamine—Dyspepsia—Temozolomide—melanoma	0.000938	0.00356	CcSEcCtD
Cysteamine—Abdominal pain—Dactinomycin—melanoma	0.000932	0.00354	CcSEcCtD
Cysteamine—Body temperature increased—Dactinomycin—melanoma	0.000932	0.00354	CcSEcCtD
Cysteamine—Hypersensitivity—Bleomycin—melanoma	0.000931	0.00353	CcSEcCtD
Cysteamine—Decreased appetite—Temozolomide—melanoma	0.000927	0.00352	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Temozolomide—melanoma	0.00092	0.00349	CcSEcCtD
Cysteamine—Fatigue—Temozolomide—melanoma	0.000919	0.00349	CcSEcCtD
Cysteamine—Constipation—Temozolomide—melanoma	0.000912	0.00346	CcSEcCtD
Cysteamine—Feeling abnormal—Carmustine—melanoma	0.000909	0.00345	CcSEcCtD
Cysteamine—Asthenia—Bleomycin—melanoma	0.000907	0.00344	CcSEcCtD
Cysteamine—Gastrointestinal pain—Carmustine—melanoma	0.000902	0.00342	CcSEcCtD
Cysteamine—Immune system disorder—Docetaxel—melanoma	0.000901	0.00342	CcSEcCtD
Cysteamine—Feeling abnormal—Temozolomide—melanoma	0.000878	0.00333	CcSEcCtD
Cysteamine—Mental disorder—Docetaxel—melanoma	0.000874	0.00332	CcSEcCtD
Cysteamine—Abdominal pain—Carmustine—melanoma	0.000872	0.00331	CcSEcCtD
Cysteamine—Body temperature increased—Carmustine—melanoma	0.000872	0.00331	CcSEcCtD
Cysteamine—Gastrointestinal pain—Temozolomide—melanoma	0.000872	0.00331	CcSEcCtD
Cysteamine—Erythema—Docetaxel—melanoma	0.000869	0.0033	CcSEcCtD
Cysteamine—Malnutrition—Docetaxel—melanoma	0.000869	0.0033	CcSEcCtD
Cysteamine—Hypersensitivity—Dactinomycin—melanoma	0.000868	0.0033	CcSEcCtD
Cysteamine—Urticaria—Temozolomide—melanoma	0.000847	0.00321	CcSEcCtD
Cysteamine—Asthenia—Dactinomycin—melanoma	0.000846	0.00321	CcSEcCtD
Cysteamine—Abdominal pain—Temozolomide—melanoma	0.000843	0.0032	CcSEcCtD
Cysteamine—Body temperature increased—Temozolomide—melanoma	0.000843	0.0032	CcSEcCtD
Cysteamine—Hypersensitivity—Carmustine—melanoma	0.000813	0.00309	CcSEcCtD
Cysteamine—Diarrhoea—Dactinomycin—melanoma	0.000806	0.00306	CcSEcCtD
Cysteamine—Vomiting—Bleomycin—melanoma	0.000803	0.00305	CcSEcCtD
Cysteamine—Anaemia—Docetaxel—melanoma	0.000803	0.00305	CcSEcCtD
Cysteamine—Rash—Bleomycin—melanoma	0.000797	0.00302	CcSEcCtD
Cysteamine—Dermatitis—Bleomycin—melanoma	0.000796	0.00302	CcSEcCtD
Cysteamine—Asthenia—Carmustine—melanoma	0.000791	0.003	CcSEcCtD
Cysteamine—Hypersensitivity—Temozolomide—melanoma	0.000785	0.00298	CcSEcCtD
Cysteamine—Leukopenia—Docetaxel—melanoma	0.000777	0.00295	CcSEcCtD
Cysteamine—Asthenia—Temozolomide—melanoma	0.000765	0.0029	CcSEcCtD
Cysteamine—Diarrhoea—Carmustine—melanoma	0.000755	0.00287	CcSEcCtD
Cysteamine—Convulsion—Docetaxel—melanoma	0.000753	0.00286	CcSEcCtD
Cysteamine—Nausea—Bleomycin—melanoma	0.000751	0.00285	CcSEcCtD
Cysteamine—Hypertension—Docetaxel—melanoma	0.00075	0.00285	CcSEcCtD
Cysteamine—Vomiting—Dactinomycin—melanoma	0.000749	0.00284	CcSEcCtD
Cysteamine—Rash—Dactinomycin—melanoma	0.000743	0.00282	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000734	0.00279	CcSEcCtD
Cysteamine—Dizziness—Carmustine—melanoma	0.000729	0.00277	CcSEcCtD
Cysteamine—Diarrhoea—Temozolomide—melanoma	0.000729	0.00277	CcSEcCtD
Cysteamine—Confusional state—Docetaxel—melanoma	0.000715	0.00271	CcSEcCtD
Cysteamine—Anaphylactic shock—Docetaxel—melanoma	0.000709	0.00269	CcSEcCtD
Cysteamine—Dizziness—Temozolomide—melanoma	0.000705	0.00268	CcSEcCtD
Cysteamine—Vomiting—Carmustine—melanoma	0.000701	0.00266	CcSEcCtD
Cysteamine—Nausea—Dactinomycin—melanoma	0.0007	0.00266	CcSEcCtD
Cysteamine—Rash—Carmustine—melanoma	0.000695	0.00264	CcSEcCtD
Cysteamine—Nervous system disorder—Docetaxel—melanoma	0.000695	0.00264	CcSEcCtD
Cysteamine—Dermatitis—Carmustine—melanoma	0.000695	0.00264	CcSEcCtD
Cysteamine—Headache—Carmustine—melanoma	0.000691	0.00262	CcSEcCtD
Cysteamine—Skin disorder—Docetaxel—melanoma	0.000689	0.00261	CcSEcCtD
Cysteamine—Vomiting—Temozolomide—melanoma	0.000678	0.00257	CcSEcCtD
Cysteamine—Anorexia—Docetaxel—melanoma	0.000676	0.00257	CcSEcCtD
Cysteamine—Rash—Temozolomide—melanoma	0.000672	0.00255	CcSEcCtD
Cysteamine—Dermatitis—Temozolomide—melanoma	0.000671	0.00255	CcSEcCtD
Cysteamine—Headache—Temozolomide—melanoma	0.000668	0.00254	CcSEcCtD
Cysteamine—Nausea—Carmustine—melanoma	0.000655	0.00249	CcSEcCtD
Cysteamine—Nausea—Temozolomide—melanoma	0.000633	0.0024	CcSEcCtD
Cysteamine—Somnolence—Docetaxel—melanoma	0.00063	0.00239	CcSEcCtD
Cysteamine—Dyspepsia—Docetaxel—melanoma	0.000624	0.00237	CcSEcCtD
Cysteamine—Decreased appetite—Docetaxel—melanoma	0.000616	0.00234	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Docetaxel—melanoma	0.000612	0.00232	CcSEcCtD
Cysteamine—Fatigue—Docetaxel—melanoma	0.000611	0.00232	CcSEcCtD
Cysteamine—Constipation—Docetaxel—melanoma	0.000606	0.0023	CcSEcCtD
Cysteamine—Feeling abnormal—Docetaxel—melanoma	0.000584	0.00222	CcSEcCtD
Cysteamine—Gastrointestinal pain—Docetaxel—melanoma	0.00058	0.0022	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—GNA11—melanoma	0.000578	0.000974	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GAB2—melanoma	0.000578	0.000974	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MC1R—melanoma	0.000577	0.000972	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000576	0.000971	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—melanoma	0.000574	0.000967	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT3—melanoma	0.00057	0.00096	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCR4—melanoma	0.000567	0.000956	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCR1—melanoma	0.000561	0.000946	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SKI—melanoma	0.000561	0.000946	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—GNAQ—melanoma	0.000561	0.000945	CbGpPWpGaD
Cysteamine—Abdominal pain—Docetaxel—melanoma	0.00056	0.00213	CcSEcCtD
Cysteamine—Body temperature increased—Docetaxel—melanoma	0.00056	0.00213	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCR7—melanoma	0.000553	0.000932	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GRM1—melanoma	0.000553	0.000932	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MC1R—melanoma	0.000553	0.000932	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—NRAS—melanoma	0.00055	0.000927	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT3—melanoma	0.000546	0.000921	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCR4—melanoma	0.000544	0.000916	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SUFU—melanoma	0.000539	0.000908	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—GNAQ—melanoma	0.000537	0.000906	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCR7—melanoma	0.00053	0.000893	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GRM1—melanoma	0.00053	0.000893	CbGpPWpGaD
Cysteamine—Hypersensitivity—Docetaxel—melanoma	0.000522	0.00198	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—AKT3—melanoma	0.000517	0.000872	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SUFU—melanoma	0.000517	0.00087	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—MYC—melanoma	0.000512	0.000863	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TP53—melanoma	0.00051	0.00086	CbGpPWpGaD
Cysteamine—Asthenia—Docetaxel—melanoma	0.000509	0.00193	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—TP53—melanoma	0.000504	0.00085	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RHOB—melanoma	0.000503	0.000848	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—BCL2L11—melanoma	0.000503	0.000848	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT3—melanoma	0.000496	0.000836	CbGpPWpGaD
Cysteamine—Diarrhoea—Docetaxel—melanoma	0.000485	0.00184	CcSEcCtD
Cysteamine—SST—Signaling Pathways—HDAC6—melanoma	0.000483	0.000814	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RHOB—melanoma	0.000482	0.000813	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BCL2L11—melanoma	0.000482	0.000813	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—EDN1—melanoma	0.000479	0.000807	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—KRAS—melanoma	0.000473	0.000798	CbGpPWpGaD
Cysteamine—Dizziness—Docetaxel—melanoma	0.000469	0.00178	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CSF2—melanoma	0.000468	0.000789	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL6—melanoma	0.000467	0.000787	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HDAC6—melanoma	0.000463	0.000781	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—melanoma	0.000461	0.000778	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—melanoma	0.00046	0.000775	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—EDN1—melanoma	0.000459	0.000773	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCR2—melanoma	0.000458	0.000772	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL8—melanoma	0.000458	0.000772	CbGpPWpGaD
Cysteamine—Vomiting—Docetaxel—melanoma	0.000451	0.00171	CcSEcCtD
Cysteamine—SST—Signaling Pathways—RAC2—melanoma	0.000451	0.00076	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PRKCA—melanoma	0.000449	0.000756	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CSF2—melanoma	0.000449	0.000756	CbGpPWpGaD
Cysteamine—Rash—Docetaxel—melanoma	0.000447	0.0017	CcSEcCtD
Cysteamine—Dermatitis—Docetaxel—melanoma	0.000447	0.0017	CcSEcCtD
Cysteamine—Headache—Docetaxel—melanoma	0.000444	0.00169	CcSEcCtD
Cysteamine—SST—Signaling Pathways—VEGFC—melanoma	0.000444	0.000748	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—WNT5A—melanoma	0.000444	0.000748	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCR2—melanoma	0.000439	0.00074	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL8—melanoma	0.000439	0.00074	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EDN1—melanoma	0.000435	0.000733	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RAC2—melanoma	0.000432	0.000728	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PRKCA—melanoma	0.00043	0.000725	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFC—melanoma	0.000425	0.000717	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—WNT5A—melanoma	0.000425	0.000717	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CSF2—melanoma	0.000425	0.000716	CbGpPWpGaD
Cysteamine—Nausea—Docetaxel—melanoma	0.000421	0.0016	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—EDN1—melanoma	0.000417	0.000702	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—RAC1—melanoma	0.000416	0.000701	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PRKCA—melanoma	0.000407	0.000687	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CSF2—melanoma	0.000407	0.000687	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—HRAS—melanoma	0.000402	0.000678	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—RAC1—melanoma	0.000399	0.000672	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAP2K2—melanoma	0.000398	0.000671	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PRKCA—melanoma	0.000391	0.000658	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—F2R—melanoma	0.00039	0.000656	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAP2K2—melanoma	0.000382	0.000643	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—RAC1—melanoma	0.000378	0.000636	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDNRB—melanoma	0.000377	0.000636	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—F2R—melanoma	0.000373	0.000629	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—melanoma	0.000371	0.000625	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTK2B—melanoma	0.000366	0.000617	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—RAC1—melanoma	0.000362	0.00061	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EDNRB—melanoma	0.000362	0.00061	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GNA11—melanoma	0.000356	0.0006	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GAB2—melanoma	0.000356	0.0006	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FLT1—melanoma	0.000355	0.000598	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CG—melanoma	0.000351	0.000592	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTK2B—melanoma	0.000351	0.000592	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GAB2—melanoma	0.000342	0.000576	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GNA11—melanoma	0.000342	0.000576	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FLT1—melanoma	0.00034	0.000573	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CG—melanoma	0.000337	0.000568	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HDAC2—melanoma	0.000335	0.000564	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCR4—melanoma	0.000335	0.000564	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FOXO4—melanoma	0.000335	0.000564	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—GNAQ—melanoma	0.000331	0.000558	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FOXO4—melanoma	0.000321	0.000541	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HDAC2—melanoma	0.000321	0.000541	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCR4—melanoma	0.000321	0.000541	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CG—melanoma	0.000319	0.000538	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—GNAQ—melanoma	0.000318	0.000535	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SYK—melanoma	0.000311	0.000525	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CD—melanoma	0.000309	0.000521	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CG—melanoma	0.000306	0.000516	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NGFR—melanoma	0.000306	0.000515	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ITGAV—melanoma	0.000306	0.000515	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT3—melanoma	0.000306	0.000515	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SYK—melanoma	0.000299	0.000503	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CD—melanoma	0.000296	0.000499	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ITGAV—melanoma	0.000293	0.000494	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NGFR—melanoma	0.000293	0.000494	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT3—melanoma	0.000293	0.000494	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SOCS1—melanoma	0.000283	0.000477	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAP2K1—melanoma	0.000282	0.000476	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—S100B—melanoma	0.000282	0.000476	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CD—melanoma	0.00028	0.000473	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SOCS1—melanoma	0.000271	0.000457	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAP2K1—melanoma	0.000271	0.000456	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—S100B—melanoma	0.000271	0.000456	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ERBB4—melanoma	0.00027	0.000455	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CB—melanoma	0.000269	0.000454	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CD—melanoma	0.000269	0.000453	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN2B—melanoma	0.000268	0.000451	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CD86—melanoma	0.000259	0.000436	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB4—melanoma	0.000259	0.000436	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL8—melanoma	0.000259	0.000436	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CB—melanoma	0.000258	0.000435	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EDN1—melanoma	0.000257	0.000433	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN2B—melanoma	0.000257	0.000432	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CSF2—melanoma	0.000251	0.000423	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGF1—melanoma	0.000251	0.000423	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CD86—melanoma	0.000248	0.000418	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—melanoma	0.000248	0.000418	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL2—melanoma	0.000247	0.000417	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EDN1—melanoma	0.000246	0.000415	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—E2F1—melanoma	0.000246	0.000414	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CB—melanoma	0.000244	0.000412	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PDGFRA—melanoma	0.000243	0.00041	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ITGB3—melanoma	0.000241	0.000406	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PRKCA—melanoma	0.000241	0.000406	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CSF2—melanoma	0.000241	0.000406	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGF1—melanoma	0.000241	0.000406	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—melanoma	0.000237	0.000399	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—SPP1—melanoma	0.000236	0.000398	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—E2F1—melanoma	0.000235	0.000397	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAP2K2—melanoma	0.000235	0.000396	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCL8—melanoma	0.000235	0.000396	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CB—melanoma	0.000234	0.000395	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PDGFRA—melanoma	0.000233	0.000393	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ITGB3—melanoma	0.000231	0.000389	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PRKCA—melanoma	0.000231	0.000389	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—SPP1—melanoma	0.000226	0.000381	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAP2K2—melanoma	0.000226	0.00038	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—melanoma	0.000225	0.00038	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL2—melanoma	0.000225	0.000378	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TERT—melanoma	0.000224	0.000377	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—RAC1—melanoma	0.000223	0.000376	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL2—melanoma	0.000215	0.000363	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TERT—melanoma	0.000214	0.000361	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HIF1A—melanoma	0.000214	0.000361	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—RAC1—melanoma	0.000214	0.00036	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HIF1A—melanoma	0.000205	0.000346	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KDR—melanoma	0.000205	0.000345	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FN1—melanoma	0.000197	0.000332	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KDR—melanoma	0.000196	0.000331	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NOTCH1—melanoma	0.000193	0.000325	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CD80—melanoma	0.000189	0.000318	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FN1—melanoma	0.000189	0.000318	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KIT—melanoma	0.000188	0.000318	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CG—melanoma	0.000188	0.000318	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—APC—melanoma	0.000188	0.000318	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NRAS—melanoma	0.000188	0.000318	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGF—melanoma	0.000186	0.000314	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NOTCH1—melanoma	0.000185	0.000311	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CD80—melanoma	0.000181	0.000305	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—APC—melanoma	0.000181	0.000305	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CG—melanoma	0.000181	0.000305	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KIT—melanoma	0.000181	0.000305	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NRAS—melanoma	0.000181	0.000305	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK3—melanoma	0.000181	0.000304	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGF—melanoma	0.000179	0.000301	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—BRAF—melanoma	0.000177	0.000299	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK3—melanoma	0.000173	0.000292	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IGF1—melanoma	0.000173	0.000291	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—MAPK1—melanoma	0.000172	0.000289	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—EGFR—melanoma	0.000172	0.000289	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—BRAF—melanoma	0.00017	0.000286	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAP2K1—melanoma	0.000167	0.000281	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CD—melanoma	0.000166	0.000279	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IGF1—melanoma	0.000165	0.000279	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—MAPK1—melanoma	0.000165	0.000278	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—EGFR—melanoma	0.000165	0.000277	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—PIK3CA—melanoma	0.000164	0.000277	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—KRAS—melanoma	0.000162	0.000273	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAP2K1—melanoma	0.00016	0.000269	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CD—melanoma	0.000159	0.000268	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FGF2—melanoma	0.000159	0.000267	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—PIK3CA—melanoma	0.000157	0.000265	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—KRAS—melanoma	0.000156	0.000262	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FGF2—melanoma	0.000152	0.000256	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—PIK3CA—melanoma	0.000149	0.000251	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MDM2—melanoma	0.000148	0.00025	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—ERBB2—melanoma	0.000146	0.000247	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CB—melanoma	0.000144	0.000243	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—PIK3CA—melanoma	0.000143	0.000241	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MDM2—melanoma	0.000142	0.00024	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—ERBB2—melanoma	0.00014	0.000236	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCL8—melanoma	0.000139	0.000234	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CB—melanoma	0.000138	0.000233	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—HRAS—melanoma	0.000138	0.000232	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1B—melanoma	0.000136	0.000228	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—AKT1—melanoma	0.000134	0.000226	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—melanoma	0.000133	0.000224	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CASP3—melanoma	0.000133	0.000224	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—melanoma	0.000133	0.000224	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—HRAS—melanoma	0.000132	0.000223	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—melanoma	0.000132	0.000222	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1B—melanoma	0.00013	0.000219	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCND1—melanoma	0.000129	0.000218	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—AKT1—melanoma	0.000129	0.000217	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CTNNB1—melanoma	0.000128	0.000216	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CASP3—melanoma	0.000127	0.000215	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—melanoma	0.000127	0.000214	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—melanoma	0.000127	0.000213	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MMP9—melanoma	0.000126	0.000212	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CDKN1A—melanoma	0.000125	0.000211	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PTEN—melanoma	0.000125	0.00021	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NFKB1—melanoma	0.000124	0.000209	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCND1—melanoma	0.000124	0.000209	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CTNNB1—melanoma	0.000123	0.000207	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—AKT1—melanoma	0.000122	0.000205	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MMP9—melanoma	0.00012	0.000203	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CDKN1A—melanoma	0.00012	0.000202	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PTEN—melanoma	0.00012	0.000202	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NFKB1—melanoma	0.000119	0.000201	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—AKT1—melanoma	0.000117	0.000197	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—VEGFA—melanoma	0.000113	0.00019	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—STAT3—melanoma	0.000112	0.000188	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NRAS—melanoma	0.000111	0.000188	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—VEGFA—melanoma	0.000108	0.000182	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT3—melanoma	0.000107	0.00018	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NRAS—melanoma	0.000107	0.00018	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK3—melanoma	0.000107	0.00018	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MYC—melanoma	0.000104	0.000175	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK3—melanoma	0.000102	0.000172	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK1—melanoma	0.000101	0.000171	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—EGFR—melanoma	0.000101	0.000171	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MYC—melanoma	9.94e-05	0.000168	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK1—melanoma	9.73e-05	0.000164	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—EGFR—melanoma	9.73e-05	0.000164	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KRAS—melanoma	9.58e-05	0.000162	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—KRAS—melanoma	9.19e-05	0.000155	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—PIK3CA—melanoma	8.8e-05	0.000148	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TP53—melanoma	8.52e-05	0.000144	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—PIK3CA—melanoma	8.44e-05	0.000142	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—TP53—melanoma	8.17e-05	0.000138	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—HRAS—melanoma	8.15e-05	0.000137	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—HRAS—melanoma	7.81e-05	0.000132	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—melanoma	7.8e-05	0.000131	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—melanoma	7.47e-05	0.000126	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—AKT1—melanoma	7.19e-05	0.000121	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—AKT1—melanoma	6.9e-05	0.000116	CbGpPWpGaD
